In order to bring you the best possible user experience, this site uses Javascript. If you are seeing this message, it is likely that the Javascript option in your browser is disabled. For optimal viewing of this site, please ensure that Javascript is enabled for your browser.
Did you know that your browser is out of date? To get the best experience using our website we recommend that you upgrade to a newer version. Learn more.

Research Priorities for Cardiovascular Disease



Strategic Research Agenda for Cardiovascular Diseases

The Strategic Research Agenda for Cardiovascular Diseases (SRA-CVD) developed by ERA-CVD, a European Research Area Network, is a blueprint for shaping CVD research priorities in Horizon Europe.

The ESC has significantly contributed as a member of the Advisory Board of ERA CVD. This Strategic Research Agenda proposes 15 topics for CVD research in three categories: prevention strategies; treatment and management; and living with chronic cardiovascular diseases.

Among the topics are:

  • Can wearables help people improve and maintain a healthy lifestyle?
  • How to anticipate and prevent heart attack, cardiac arrest and stroke.
  • Using data on genetics, physical and mental health and socioeconomic status to tailor risk assessment, lifestyle advice and preventive treatment.
  • How CVD interacts with cancer and diabetes and the potential for combined treatments.
  • Clarifying the biological, behavioural and social mechanisms of CVD in women versus men.
  • Understanding the crosstalk between cognitive decline and CVD to jointly tackle both conditions.
  • Ways to support CVD patients with depression, anxiety and extreme tiredness.
  • What CVD patients and caregivers need and expect from healthcare providers at the end of life.
  • Research on new advanced cell-derived therapies to detain the progression of acute heart disease to heart failure.